Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP549261.RAQzVrn78aQZsOQ3nuaDbNuAWx7i22m4lyVDfDzk-hDTQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP549261.RAQzVrn78aQZsOQ3nuaDbNuAWx7i22m4lyVDfDzk-hDTQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP549261.RAQzVrn78aQZsOQ3nuaDbNuAWx7i22m4lyVDfDzk-hDTQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP549261.RAQzVrn78aQZsOQ3nuaDbNuAWx7i22m4lyVDfDzk-hDTQ130_provenance.
- NP549261.RAQzVrn78aQZsOQ3nuaDbNuAWx7i22m4lyVDfDzk-hDTQ130_assertion description "[In this study, a decrease in matrix metalloprotease-9 (MMP-9) but not of MMP-2 and the tissue inhibitors of MMP (TIMP-1 and TMP-2) was observed in the plasma of chronic hepatitis C patients at the end of the follow-up period after ribavirin plus interferon-alpha2b (PEG-IFN-alpha2b) treatment in sustained virologic responders but not in nonresponders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549261.RAQzVrn78aQZsOQ3nuaDbNuAWx7i22m4lyVDfDzk-hDTQ130_provenance.
- NP549261.RAQzVrn78aQZsOQ3nuaDbNuAWx7i22m4lyVDfDzk-hDTQ130_assertion evidence source_evidence_literature NP549261.RAQzVrn78aQZsOQ3nuaDbNuAWx7i22m4lyVDfDzk-hDTQ130_provenance.
- NP549261.RAQzVrn78aQZsOQ3nuaDbNuAWx7i22m4lyVDfDzk-hDTQ130_assertion SIO_000772 16108728 NP549261.RAQzVrn78aQZsOQ3nuaDbNuAWx7i22m4lyVDfDzk-hDTQ130_provenance.
- NP549261.RAQzVrn78aQZsOQ3nuaDbNuAWx7i22m4lyVDfDzk-hDTQ130_assertion wasDerivedFrom befree-20140225 NP549261.RAQzVrn78aQZsOQ3nuaDbNuAWx7i22m4lyVDfDzk-hDTQ130_provenance.
- NP549261.RAQzVrn78aQZsOQ3nuaDbNuAWx7i22m4lyVDfDzk-hDTQ130_assertion wasGeneratedBy ECO_0000203 NP549261.RAQzVrn78aQZsOQ3nuaDbNuAWx7i22m4lyVDfDzk-hDTQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP549261.RAQzVrn78aQZsOQ3nuaDbNuAWx7i22m4lyVDfDzk-hDTQ130_provenance.